DGX - Quest Diagnostics Short-Term Debt to Capital

Quest Diagnostics relies on a broad customer base and genetics for growth. The short-term debt-to-equity ratio demonstrates the current credit load, and this metric equals 0.07. Home tests and government rates create risks, while internal order is maintained through strict compliance and stable benefits for medical personnel.

Quest Diagnostics has successfully stabilized core demand, offsetting the impact of the pandemic cycle's conclusion. By analyzing changes in the short-term debt-to-equity ratio, investors assess the proportion of liabilities due within one year relative to equity. This metric determines the company's dependence on current refinancing rates amid rising personnel costs. A low short-term debt load confirms the financial resilience of the stock's valuation against macroeconomic shocks.